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Case Number 6
Mucinous Cystadenocarcinoma of the Appendix
Elena Farrugia and Maria Grazia Grech
Reviewed by: Mr. Dennis T. Gatt L.R.C.P. (Lond.), F.R.C.S. (Eng.), F.R.C.S. (Edin.)
Case summary:
Demographic details:
Ms. GM, female, 67 years.
Referred from hospital.
GM, a 67-year-old female, was referred after an appendiceal mucocoele which had been noted and 
removed during a total abdominal hysterectomy with bilateral oophorectomy (TAH-BSO) was diagnosed 
on histopathology as being a mucinous cystadenocarcinoma. The patient presented with no signs or 
symptoms. The patient subsequently underwent a laparoscopic right hemicolectomy and is being followed 
up at surgical outpatients yearly to exclude recurrence of the malignancy. 
Presenting complaint:
The patient was admitted for laparoscopic right hemicolectomy after an appendiceal mass removed during 
a TAH-BSO procedure was diagnosed as being a mucinous cystadenocarcinoma on histopathology. 
History of presenting complaint:
The patient had been admitted for a TAH-BSO procedure after a 7 x 7.8cm complex mass was seen on 
ultrasound in the right adnexa, which was subsequently confirmed on CT scan as being a cystic mass 
arising from the right ovary. During surgery however, while the ovaries and the uterus looked normal, a 
large appendiceal mucocoele was noted and removed via appendectomy. This was then sent to histology 
where it was diagnosed as being mucinous cystadenocarcinoma.
Past medical and surgical history:
Past medical history:
Depression
Past drug history
Total abdominal hysterectomy with bilateral salpingo-oophorectomy on 6/4/2010
Drug history:
Drug Name Dosage Route Frequency Reason
Paroxetine 20mg PO BD Anti-depressant
Flupentixol 0.5mg PO BD Anti-psychotic 
Lorazepam 1mg PO BD Anti-anxiety
No known drug allergies or anaesthetic problems.
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Family history:
No relevant family history.
Social history:
The patient lives with her daughter. She is now retired and used to work as a cleaner. The patient is a non-
smoker and does not drink alcohol. 
Systemic inquiry: 
• General Health: Good and active. Patient looked comfortable after operation
• Cardiovascular System: Nil to note
• Respiratory System: Nil to note
• Gastrointestinal System: Some tenderness close to the operation site for the TAH-BSO procedure
• Genitourinary System: Nil to note
• Central Nervous System: Nil to note
• Musculoskeletal System: Nil to note
• Endocrine System: Nil to note
Discussion of results of general and specific examinations
General examination of the patient was unremarkable. The patient appeared healthy, with no physical 
signs and symptoms of mucinous cystadenocarcinoma. The patient was not pale, jaundiced or cyanosed. 
There were no evident signs of recent weight loss and the patient denied recent rapid weight loss. She 
was afebrile.
Cardiovascular and respiratory examinations were also unremarkable. These revealed normal heart 
sounds S1+S2+0, with equal air entry in both lungs and normal vesicular breath sounds. A Pfannenstiel 
incision was observed on the abdomen due to the TAH-BSO. The abdominal examination did not reveal 
any masses or organomegaly. There was no guarding or rebound tenderness. There was some slight 
suprapubic tenderness close to the TAH-BSO operation site.  Normal bowel sounds were auscultated and 
stools were normal.  
Differential diagnosis:  
• Mucinous cystadenocarcinoma
• Carcinoid tumour of  the appendix 
• Mucosal hyperplasia
• Adjacent caecal tumour 
• Inspissated mucous causing obstruction
• Appendiceal mucinous cystadenoma
• Appendiceal mucinous adenoma
• Appendiceal adenoma
• Appendiceal ganglioneuroma
• Appendiceal paraganglioma
• Appendiceal lymphoma
• Appendiceal mucinous adenocarcinoma
• Appendiceal adenocarcinoma 
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Diagnostic procedures:
Laboratory exams:
Test: Appendix specimen taken during TAH-BSO surgery for histology. 
Justification for test: Appendiceal mucocoele noted and removed during surgery. 
Results: The specimen was that of a previously opened appendix measuring 110 x 55 x 17mm. Examination 
of its mucosal surface showed numerous papillary projections into the lumen and extensive mucoid clots. 
Also submitted was a yellowish, mucoid mass measuring 180 x 100 x 15mm.
On microscopy, sections from appendix showed malignant cells with vesicular nuclei and prominent 
nucleoli and frequent mitotic figures invading the full thickness of the appendiceal wall with a desmoplastic 
stromal reaction.
Conclusion: Mucinous cystadenocarcinoma was diagnosed.
Test: Colon and ileum removed during right hemicolectomy for pathology.
Justification of test: To confirm that there was no residual malignancy and for adequate clearance of the 
drainage lymph nodes.
Results: Terminal ileum measuring 48mm in length as well as attached colon measuring 160mm were 
submitted.  Obviously no appendix was present. On opening, no mass was present.
On microscopy, both the ileal and colonic resection margins were free of tumour. There was no residual 
tumour although there were a number of diverticula present.
Conclusion: No residual malignancy was present.
Therapy:
Surgical therapy:
Pre-operative: The patient had been advised to take Dulcolax 5mg two days prior to admission as well 
as another 5mg a day before admission. The patient was admitted to the surgical wards from admission 
lounge a day before the surgery for bowel preparation. Two sachets of Klean-Prep were given. A chest 
X-Ray and an ECG were carried out. Blood tests were taken and cross-match was carried out for two 
units of blood. Stool charting was done.  Informed consent was obtained.
Operation: Laparoscopic right hemicolectomy. 
Insufflation was used at 12mmHg. 4 ports were used. Dense adhesions from the previous surgery were 
noted. Routine lateral to medial right hemicolectomy was carried out. Specimens were obtained in a bag 
for histology. The ileal and the colonic margins were anastomosed together via a GIA stapler. 
A drain to remove blood or potential anastomotic leakage, a nasogastric tube for gastric decompression 
and a urinary catheter were inserted.
Post-operative: The patient removed the nasogastric tube a day after surgery. The urinary catheter was 
removed two days after surgery. The patient passed flatus two days after surgery and opened bowels three 
days after surgery. The drain was removed four days after surgery. The patient was kept nil by mouth for 
five days after surgery.
The post-operative medications were as follows:  
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Drugs:
 
Drug Dosage Route Frequency Reason
Paracetamol 1g PO 6hrly / PRN Pain relief
Cefuroxime          
(Zinacef)
750mg PO BD Prophylactic broad-      
spectrum antibiotic 
Metronidazole    
(Flagyl)
400mg PO TDS Prophylaxis against        
anaerobic organisms and 
protozoa
Minihep 5000 IU SC Daily Prophylactic 
anticoagulant to prevent 
thromboembolism
Metoclopramide 
(Maxolon)
10mg IV 6hrly/PRN To control nausea and 
vomiting post-operatively
Pethidine 75mg IM PRN Pain relief
Paroxetine 20mg PO BD Anti-depressant
Flupentixol 0.5mg PO BD Anti-psychotic 
Lorazepam 1mg PO BD Anti-anxiety
Diagnosis:
The diagnosis was made by histological examination of the appendix and the mucocoele removed during 
the TAH-BSO.  Mucinous cystadenocarcinoma is a low grade malignancy 1 and one type of appendicular 
mucocoele. The other types, in order of increasing severity, are: retention cyst, mucosal hyperplasia and 
mucinous cystadenoma. Mucinous cystadenocarcinoma is however the most severe form of them all. 
This classification2, created by the World Health Organization3, is based primarily on epithelial structure. 
Neoplastic epithelium and a severe distention of the appendicular lumen are required to diagnose mucinous 
cystadenocarcinoma histologically2. There is also invasion of the glandular stroma, desmoplastic reaction 
and presence of epithelial cells in peritoneal implants4. The massive growth of the appendix lumen is 
caused by these cancer cells producing vast amounts of mucin and these cells may spread within the 
peritoneum causing pseudomyxoma peritonei1. In fact, the latter syndrome is found in 50% of cases5 and 
involves mucinous ascites and is more informally known as “jelly belly”4. The appendicular mucocoeles 
make up only 0.2-0.4% of appendectomy surgical specimens and mucinous cystadenoma forms 11-
20% of these cases2. It also forms less than 0.5% of intestinal tumours5. Therefore, this condition is 
quite rare2. Patients who develop mucinous cystadenocarcinoma are usually younger than patients with 
adenocarcinoma of the appendix4.    
It is difficult to ascertain a mucocoele’s presence preoperatively even if a meticulous physical examination 
is carried out4. Most mucocoeles are asymptomatic so are only found incidentally. However, when 
symptoms are present they depend on how complicated the disease is. There is a range of symptoms and 
signs from a palpable mass in slim patients, right lower quadrant pain, signs of intussusception and bowel 
obstruction including colicky pain, gastrointestinal bleeding and therefore anaemia to acute abdomen 
with sepsis3. 
Carcinoembryonic antigen may be elevated5. Conventional imaging techniques make it difficult to 
distinguish mucinous cystadenocarcinoma from adenoma. However, ultrasound and computed tomography 
(CT) scan are effective at detecting mucocoeles6. CT scan is the best imaging modality for preoperative 
planning of tumour resection as it has an overall sensitivity of 93% for detection of mucocoele rupture, 
peritoneal mucinous carcinomatosis or pseudomyxoma peritonei and wall calcification5. Furthermore, 
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contrast enhanced ultrasonography was used along with CT scan and ultrasound to pre-operatively diagnose 
mucinous cystadenocarcinoma6. Generally, endoscopy cannot access the appendix for investigation 
however it may detect other tumours growing simultaneously with the mucinous cystadenocarcinoma in 
the colon of 13% of patients with mucocoeles. Even though sometimes the mucosal biopsies taken are 
normal, colonoscopy is useful in distinguishing benign from malignant lesions3. Examination of frozen 
sections taken during surgery and histopathological examination of the specimen after surgery can be 
carried out for diagnosis5.
Removing the tumour early may cure the patient. An acceptable form of definitive therapy is right 
hemicolectomy5, 1 and is preferable to appendectomy alone as its 10-year survival rate is 65% while 
that after appendectomy is 37%. However, if there is no pre-operative evidence of other tumours and 
no evidence at surgery of the tumour having spread to the peritoneum (the peritoneum surrounding not 
just the appendix but also of the liver and pelvis must be checked for tumour deposits and/or mucus and 
if these are present samples are taken for histopathological and cytological examination) or invaded the 
lymph nodes, appendectomy is sufficient to treat the mucocoele. 
One surgical treatment suggested, based on the fact that usually mucinous appendicular tumours spread 
through the wall and rarely to the lymph nodes, is resection of the tumour along with retrocaecal 
appendiceal lymph nodes and these are sent for frozen section. If these sections are negative appendectomy 
only is enough. This is not the case if the lymph nodes are positive in that case right hemicolectomy is 
performed. Open surgery to remove the appendix is preferable to laparoscopy as it lessens the chance 
of perforation and hence pseudomyxoma peritonei however, if the surgeon sees that the chance of 
perforation is not that high laparoscopy may be done.  If the tumour disseminated, then along with right 
hemicolectomy, aggressive debulking; oophorectomy and omentectomy are beneficial. Bowel obstruction 
and/or fistulation often occur so the patient would need to undergo repeated operations. Radiotherapy and 
chemotherapy are not effective in disseminated disease. Mucinous cystadenocarcinoma tumours grow 
slower than appendiceal adenocarcinomas which means they have a better prognosis5.
Prognosis in the long term is affected adversely by perforation of the tumour and leakage of mucus into 
the peritoneal cavity. In fact, patients with spread beyond the appendix only have a 45% survival after 
5 years as compared with 100% survival after 5 years in patients with low grade mucinous tumours 
confined to the appendix. No follow up is needed in the latter cases3.
Final treatment and follow ups:
The patient was discharged ten days after surgery. The patient was seen 6 weeks later in surgical outpatients. 
The patient will be followed up yearly at surgical outpatients to exclude recurrence of malignancy. The 
patient has already survived for four years since the surgery. 
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Fact Box 6:
Title: Mucinous Cystadenocarcinoma
Mucinous cystadenocarcinoma is the fourth type of appendicular mucocoele in a grouping system chiefly 
based on the structure of the epithelium. This forms 11-20% of appendicular mucocoeles. The epithelium 
is neoplastic1; desmoplastic reaction and glandular stromal invasion are present and (but not necessarily) 
epithelial cells can be found in the peritoneal implants2. The lumen of the appendix is also severely 
distended1. This may result in rupture which results in mucinous dissemination into the peritoneum which 
causes mucinous ascites that is named pseudomyxoma peritonei. This syndrome is more informally 
known as “jelly belly”. There is also a high chance of metastasis to the liver and lymph nodes. Patients 
suffering from this condition have a poor prognosis2.     
Risk factors:
Females of middle and older age are mostly affected by appendicular mucocoeles therefore of mucinous 
cystadenocarcinoma6. Kalmon and Winningingham7 identified three factors which may lead to mucocoele 
formation in the appendix: aseptic content, continuous mucus production and narrowing of the valvular 
opening of the appendix. Obstruction of the appendix may be caused by bending, torsion, inflammation 
and ileocaecal tumour6.
Signs and Symptoms:2
How the patient presents depends on whether the mucocoele ruptures or not. If it does not rupture, the 
majority of patients are asymptomatic and it is difficult to ascertain the mucocoele’s presence preoperatively 
even if a meticulous physical examination is done2. That is, the symptoms are non-specific. However, 
some patients may suffer from pain or even just discomfort and have a palpable mass in the right lower 
quadrant3. The condition is an incidental finding during or after an operation via histological testing2.
Investigations and diagnosis: 2
Conventional imaging techniques make it difficult to distinguish mucinous cystadenocarcinoma from 
adenoma. Furthermore, surgery immediately ensues after diagnosis so as to avoid rupture. However, 
ultrasound and computed tomography scan are effective at detecting mucocoeles3.
Prevention:
Treatment depends on the extent of the condition. Ileocaecal resection is performed3.Sodium oxybate for 
nighttime use.
Prognosis:
Prognosis in the long term is affected adversely by perforation of the tumour and leakage of mucus into 
the peritoneal cavity. In fact, patients with spread beyond the appendix only have a 45% survival after 
5 years as compared with 100% survival after 5 years in patients with low grade mucinous tumours 
confined to the appendix4.
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